Arrowhead Pharmaceuticals (ARWR) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Buy ARWR with Qtrade Free ARWR Stock Alerts $21.87 -1.42 (-6.10%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Down 8%marketbeat.com - April 25 at 8:23 PMArrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Resultsbusinesswire.com - April 24 at 4:01 PMArrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Diseasebusinesswire.com - April 24 at 7:30 AMArrowhead Pharmaceuticals (NASDAQ:ARWR) Trading Up 7.5%marketbeat.com - April 22 at 4:46 PMArrowhead Pharmaceuticals, Inc. (ARWR)ca.finance.yahoo.com - April 21 at 10:57 PMMutual of America Capital Management LLC Cuts Stock Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - April 21 at 4:52 AMInstitutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year lossesfinance.yahoo.com - April 16 at 10:15 AMMirae Asset Global Investments Co. Ltd. Sells 102,385 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - April 15 at 5:17 AMArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 11 at 2:30 AMBuy Rating Affirmed for Arrowhead Pharmaceuticals Following Promising Plozasiran Trial Resultsmarkets.businessinsider.com - April 10 at 5:04 PMArrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expobusinesswire.com - April 7 at 9:00 AMAssenagon Asset Management S.A. Sells 381,964 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - April 6 at 4:40 AMThe 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024investorplace.com - April 5 at 4:30 PMArrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Down 7.2% marketbeat.com - April 2 at 5:45 PMSG Americas Securities LLC Cuts Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 31 at 4:16 AMArrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade)seekingalpha.com - March 30 at 5:16 AMVanguard Group Inc. Sells 113,415 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 29 at 4:10 AMArrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Datafinance.yahoo.com - March 25 at 8:43 AMArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Director Acquires $27,490.00 in Stockinsidertrades.com - March 21 at 10:33 AMArrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 6.3% After Insider Buying Activitymarketbeat.com - March 21 at 10:29 AMArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Director Hongbo Lu Purchases 1,000 Sharesmarketbeat.com - March 20 at 10:22 PMExchange Traded Concepts LLC Takes Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 18 at 6:00 AMCitigroup Inc. Raises Stock Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 17 at 5:09 AMNoteworthy Thursday Option Activity: ARWR, RBLX, MRNAnasdaq.com - March 16 at 9:45 AMARWR Apr 2024 20.000 putfinance.yahoo.com - March 16 at 9:45 AMARWR Apr 2024 25.000 callfinance.yahoo.com - March 16 at 9:45 AMBiotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?stocknews.com - March 15 at 8:02 PMHudson Bay Capital Management LP Buys 47,500 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 15 at 7:18 AMAnalysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Arrowhead Pharmaceuticals (ARWR)markets.businessinsider.com - March 14 at 11:33 PM7 Biotech Stocks to Buy as Sector Rotation Ramps Upinvestorplace.com - March 13 at 2:25 PMArrowhead Pharmaceuticals Inc ARWRmorningstar.com - March 12 at 11:34 PMQube Research & Technologies Ltd Purchases 35,463 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 12 at 4:34 AMThe 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024investorplace.com - March 11 at 6:53 PMInsider Selling: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CFO Sells 40,000 Shares of Stockinsidertrades.com - March 11 at 5:48 AMGSA Capital Partners LLP Buys New Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 9 at 7:47 AMArrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Sharesfinance.yahoo.com - March 9 at 12:00 AMArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CFO Sells $1,407,600.00 in Stockmarketbeat.com - March 8 at 7:30 PMArrowhead Pharmaceutical Gains Over Initiation Of Phase 1/2a Study Of ARO-DM1markets.businessinsider.com - March 8 at 1:59 PMArrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophybusinesswire.com - March 8 at 7:30 AMNorthern Trust Corp Sells 31,682 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - March 7 at 5:21 AMArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Short Interest Up 13.6% in Februarymarketbeat.com - March 4 at 8:40 AMArrowhead Pharmaceuticals jumps amid takeover speculationmsn.com - February 28 at 6:47 PMAvidity Partners Management LP Grows Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - February 27 at 4:25 PMArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Acquired by Invesco Ltd.marketbeat.com - February 26 at 5:50 AM7 Oversold Russell 2000 Stocks to Add to Your February Buy Listinvestorplace.com - February 25 at 6:30 AMCommonwealth of Pennsylvania Public School Empls Retrmt SYS Reduces Stock Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - February 25 at 4:41 AMArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Bought by UBS Group AGmarketbeat.com - February 24 at 4:34 AMCharles Schwab Investment Management Inc. Sells 300,074 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - February 23 at 4:33 AMCitigroup Inc. Has $4.35 Million Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - February 21 at 5:43 AMAigen Investment Management LP Acquires 25,120 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)marketbeat.com - February 20 at 8:39 AM Get Arrowhead Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). ARWR Media Mentions By Week ARWR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARWR News Sentiment▼0.240.41▲Average Medical News Sentiment ARWR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARWR Articles This Week▼64▲ARWR Articles Average Week Get Arrowhead Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HUTCHMED News ACADIA Pharmaceuticals News IDEAYA Biosciences News MoonLake Immunotherapeutics News Amicus Therapeutics News Xenon Pharmaceuticals News MorphoSys News Indivior News Bausch Health Companies News Janux Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARWR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
